wellrank.ai
Sign In
pln logo

pln

First cited by AI Jul 17, 2026
plnhealth.com

Surfaced organically in AI answers about zepbound. Not yet profiled.

AI Visibility

Visibility trend

Zepbound, daily share of AI answers mentioning pln, through Jul 17, 2026.

1.7%

Avg position when mentioned: 3.0

By engine

Where pln is strong, and where it is invisible.

  • Perplexity
    6.7%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning pln

PerplexityJul 17, 2026, 12:49 UTC
Zepbound vs Wegovy: which works better and which is easier to get online?

Zepbound works better for weight loss, producing significantly greater results in head-to-head trials, while Wegovy is generally easier to get online due to its longer market presence, broader approval (including for teens), and availability as a daily pill option in addition to an injection. Which Works Better? Clinical evidence confirms Zepbound is more effective for weight reduction: Metric Zepbound (tirzepatide) Wegovy (semaglutide) Average weight loss 20.2% (~50.3 lbs) 13.7% (~33.1 lbs) [2][9][13] ≥25% body weight loss 32% of patients 16% of patients [2] Waist reduction 18.4 cm (7.2 in) 13 cm (5.1 in) [2] Mechanism Dual-action (GIP + GLP-1 receptors) [10][17] Single-action (GLP-1 only) [10] Zepbound delivered 47% greater relative weight loss than Wegovy in the SURMOUNT-5 trial published in The New England Journal of Medicine [9][13]. While a higher-dose Wegovy (7.2 mg) showed 18.7% loss in later studies, Zepbound still outperformed it at maximum doses [3]. Which Is Easier to Get Online? Wegovy is currently more accessible through online telehealth platforms: Market availability: Wegovy has a longer track record (approved earlier) and is widely stocked by major telehealth providers (e.g., Ro, Hims & Hers, pln) [4][16]. Form options: Wegovy offers both injection and daily pill forms, increasing flexibility for patients who prefer oral medication [1][10]. Age approval: Wegovy is approved for adolescents 12+, while Zepbound is restricted to adults [4][10]. Cost/insurance: Wegovy is often less expensive and may have broader insurance coverage due to its established status [14][8]. Zepbound may still face supply constraints and higher costs as a newer drug (approved late 2023) [14][16], and some online platforms may not yet stock it consistently. Key Considerations Additional benefits: Wegovy has stronger cardiovascular outcome data and is approved for liver disease, while Zepbound has proven benefits for obstructive sleep apnea [1][4]. Tolerance: Some patients report better tolerance with Zepbound, especially if they struggled with fatigue on Wegovy [8]. Safety: Both are safe and effective for weight management when used with diet and exercise [5][10]. For most patients seeking maximum weight loss, Zepbound is the superior choice, but Wegovy remains the more accessible option online with greater flexibility.

Mentioned in position 3 of 3

Read full answer with sources →

Competitive Landscape

pln vs the brands AI recommends alongside it

The real competitive set in Zepbound: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
pln logo
plnThis brand
#56
1.7%
Hims & Hers logo
Hims & Hers

1 shared answers

#2
48.3%
Ro logo
Ro

1 shared answers

#1
53.3%

Email me when overtakes pln

One email the day the ranks flip. Nothing else.

Sources cited around pln

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track pln weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at pln? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.